Imaging Characteristics in the Ataxia-Neuropathy Spectrum Related to POLG Mutation.
4 affiliations
- 1Medical School, Lincoln Memorial University - DeBusk College of Osteopathic Medicine, Knoxville, USA.
- 2Medical School, Royal College of Surgeons in Ireland - Bahrain, Bahrain, BHR.
- 3Neurology Department, Hamad Medical Corporation, Al-Khor, QAT.
- 4Neurology Department, Hamad Medical Corporation, Doha, QAT.
Abstract
Mutations in the mitochondrial DNA polymerase gamma (POLG) gene cause a broad spectrum of neurodegenerative disorders, including the ataxia-neuropathy spectrum (ANS). Substantial phenotypic heterogeneity and overlapping clinical features can delay diagnosis. We report a 38-year-old woman with no significant past medical history who presented with a three-year history of slowly progressive sensory ataxia that worsened in the dark. Examination revealed mild dysarthria, large-fiber sensory loss, and a positive Romberg sign. Extensive metabolic, toxic, autoimmune, and infectious work-up was unrevealing. Nerve conduction studies confirmed a mild peripheral sensory neuropathy. Brain magnetic resonance imaging (MRI) demonstrated distinct bilateral, symmetric T2-weighted and fluid-attenuated inversion recovery (FLAIR) hyperintensities in the dorsomedial thalami and cerebellar white matter. Whole-exome sequencing confirmed a homozygous W748S mutation in the POLG gene, establishing a diagnosis of POLG-related ANS. This imaging pattern, though not specific to POLG-related disease, may support earlier consideration of targeted genetic testing when present alongside a compatible clinical picture.
Related
- SLC52A2-Related Riboflavin Transporter Deficiency in Non-Isolated Auditory Neuropathy: Evidence from a Chinese Cohort and a Global Variant Review
- Cochlear Implants Versus Hearing Aids in Children With Auditory Neuropathy Spectrum Disorder: A Systematic Review
- A robust mutation spectrum analysis framework for high-depth error-corrected sequencing data
- Updates in TECTA Mutation Spectrum: A Scoping Review.
- Clinical characteristics and early hematoma dynamics in a selected cohort of 199 patients with spontaneous intracerebral hemorrhage who underwent 24-hour follow-up imaging: a retrospective single-center study
BibTeX
@article{alhatou2026imaging,
title = {{Imaging Characteristics in the Ataxia-Neuropathy Spectrum Related to POLG Mutation.}},
author = {Abraham Alhatou and Omar M Alhatou and Mohamed Ghamoodi and Mohammed Alhatou},
journal = {Cureus},
year = {2026},
month = sep,
doi = {10.7759/cureus.116575},
url = {https://europepmc.org/article/MED/42903362},
note = {CC BY},
}
RIS
TY - JOUR
TI - Imaging Characteristics in the Ataxia-Neuropathy Spectrum Related to POLG Mutation.
AU - Abraham Alhatou
AU - Omar M Alhatou
AU - Mohamed Ghamoodi
AU - Mohammed Alhatou
PY - 2026
DA - 2026/09/20
JO - Cureus
DO - 10.7759/cureus.116575
UR - https://europepmc.org/article/MED/42903362
AB - Mutations in the mitochondrial DNA polymerase gamma (POLG) gene cause a broad spectrum of neurodegenerative disorders, including the ataxia-neuropathy spectrum (ANS). Substantial phenotypic heterogeneity and overlapping clinical features can delay diagnosis. We report a 38-year-old woman with no significant past medical history who presented with a three-year history of slowly progressive sensory ataxia that worsened in the dark. Examination revealed mild dysarthria, large-fiber sensory loss, and a positive Romberg sign. Extensive metabolic, toxic, autoimmune, and infectious work-up was unrevealing. Nerve conduction studies confirmed a mild peripheral sensory neuropathy. Brain magnetic resonance imaging (MRI) demonstrated distinct bilateral, symmetric T2-weighted and fluid-attenuated inversion recovery (FLAIR) hyperintensities in the dorsomedial thalami and cerebellar white matter. Whole-exome sequencing confirmed a homozygous W748S mutation in the POLG gene, establishing a diagnosis of POLG-related ANS. This imaging pattern, though not specific to POLG-related disease, may support earlier consideration of targeted genetic testing when present alongside a compatible clinical picture.
SN - 2168-8184
ER -